ロード中...
Endothelial human dihydrofolate reductase low activity limits vascular tetrahydrobiopterin recycling
Tetrahydrobiopterin (BH(4)) is required for NO synthesis and inhibition of superoxide release from eNOS. Clinical trials using BH(4) to treat endothelial dysfunction have produced mixed results. Poor outcomes may be explained by the rapid systemic and cellular oxidation of BH(4). One of the oxidatio...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3748942/ https://ncbi.nlm.nih.gov/pubmed/23707606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.freeradbiomed.2013.04.035 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|